Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pilot Study of Pembrolizumab and Single-Fraction, Low-Dose, Radiation Therapy in Patients With Relapsed or Refractory Multiple Myeloma

NCT03267888 is registered in ClinicalTrials.gov with Emory University as lead sponsor.

NCT NCT03267888
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03267888 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pilot Study of Pembrolizumab and Single-Fraction, Low-Dose, Radiation Therapy in Patients With Relapsed or Refractory Multiple Myeloma
Lead sponsor
Emory University
Phase
Phase 1/2
Overall status
Completed
Start date
May 29, 2018
Completion date
September 2, 2022
Enrollment
25 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

iss stage i plasma cell myeloma, iss stage ii plasma cell myeloma, iss stage iii plasma cell myeloma, recurrent plasma cell myeloma, refractory plasma cell myeloma